Pages that link to "Q193529"
Jump to navigation
Jump to search
The following pages link to T-lymphocytes (Q193529):
Displaying 50 items.
- AIDS (Q12199) (← links)
- natural killer T cell (Q224930) (← links)
- cytotoxic T cell (Q376266) (← links)
- T helper cell (Q632518) (← links)
- T helper 17 cell (Q768227) (← links)
- regulatory T cell (Q1550619) (← links)
- memory T cell (Q2304808) (← links)
- gamma delta T cell (Q3077796) (← links)
- mucosal associated invariant T cell (Q6931258) (← links)
- naive T cell (Q6959842) (← links)
- T helper 3 cell (Q7672695) (← links)
- Category:T cells (Q8825554) (← links)
- Th22 cell (Q11951724) (← links)
- (Q12430071) (redirect page) (← links)
- (Q13112261) (redirect page) (← links)
- T cell differentiation (Q14863504) (← links)
- T cell selection (Q14865397) (← links)
- Treg17 cell (Q18354216) (← links)
- human immunodeficiency virus infectious disease (Q18556697) (← links)
- T cell receptor V(D)J recombination (Q21105066) (← links)
- Memory of infections: an emerging role for natural killer cells (Q21131375) (← links)
- Altered T-Cell Responses by the Periodontal Pathogen Porphyromonas gingivalis (Q21134053) (← links)
- Atara Biotherapeutics, Inc. (Q21874220) (← links)
- The B-cell surface protein CD72/Lyb-2 is the ligand for CDS (Q24317139) (← links)
- Intermediate uveitis (Q24622474) (← links)
- How can cryptic epitopes trigger autoimmunity? (Q24678950) (← links)
- Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation (Q24797866) (← links)
- Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition (Q24801995) (← links)
- T-cell vaccine (Q25098576) (← links)
- The cancer stem cell: evidence for its origin as an injured autoreactive T cell (Q25256839) (← links)
- (Q25481137) (redirect page) (← links)
- How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? (Q26748867) (← links)
- Myeloid-Derived Suppressor Cells in Bacterial Infections (Q26749373) (← links)
- From kinetics and cellular cooperations to cancer immunotherapies (Q26750783) (← links)
- Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects (Q26753082) (← links)
- Impact of Alcohol Abuse on the Adaptive Immune System (Q26773237) (← links)
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy (Q26773309) (← links)
- New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells (Q26774372) (← links)
- Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy (Q26779938) (← links)
- A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer (Q26781856) (← links)
- Immunopathogenic Background of Pars Planitis (Q26781909) (← links)
- CAR T Cell Therapy: A Game Changer in Cancer Treatment (Q26822769) (← links)
- The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy (Q26859775) (← links)
- CTLA-4 blockade in tumor models: an overview of preclinical and translational research (Q26992295) (← links)
- Role of natural killer and Gamma-delta T cells in West Nile virus infection (Q27007830) (← links)
- Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges (Q27025300) (← links)
- Defining the nature of human γδ T cells: a biographical sketch of the highly empathetic (Q27026152) (← links)
- Targeting the tumor vasculature to enhance T cell activity (Q27026329) (← links)
- Genetically modified T cells in cancer therapy: opportunities and challenges (Q27026627) (← links)
- Autoimmune enteropathy with a CD8+ CD7-T-cell small bowel intraepithelial lymphocytosis: case report and literature review (Q27027444) (← links)